MICARDIS PLUS

This brand name is authorized in Australia, Austria, Canada, Croatia, Cyprus, Ecuador, Estonia, Finland, France, Germany, Hong Kong SAR China, Ireland, Italy, Lithuania, Mexico, Netherlands, Poland, Romania, Singapore, Spain, Tunisia, Turkey, UK.

Active ingredients

The drug MICARDIS PLUS contains a combination of these active pharmaceutical ingredients (APIs):

1	Telmisartan UNII U5SYW473RQ - TELMISARTAN
	Telmisartan is an orally active and specific angiotensin II receptor (type AT1) antagonist. Telmisartan selectively binds the AT1 receptor. The binding is long-lasting.
	Read more about Telmisartan
2	Hydrochlorothiazide UNII 0J48LPH2TH - HYDROCHLOROTHIAZIDE
	Hydrochlorothiazide is a diuretic with antihypertensive properties. It acts by inhibiting the renal tubular re-absorption of sodium and chloride ions, which are excreted with an accompanying volume of water. Potassium excretion is also promoted.
	Read more about Hydrochlorothiazide

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C09DA07	Telmisartan and diuretics	C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09D Angiotensin II antagonists, combinations → C09DA Angiotensin II antagonists and diuretics
Discover more medicines within C09DA07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	8622T, 8623W, 9381R
CA	Health Products and Food Branch	02244344, 02318709
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00079444, 00079467, 00539779, 00646937, 01275615, 02286288, 02286383, 02554381, 03442075, 04173677, 04215016, 04215022, 04215039, 04320405, 04348036, 05871076, 05981008, 06063361, 06063390, 06581699, 06581736, 06581765, 08466979, 08467022, 10276826, 10276832, 10276849, 12581002, 13987574, 16705412, 17146110
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	24.918-01-03, 28890-06-09
EE	Ravimiamet	1114748, 1114759, 1114760, 1114771, 1114782, 1114793, 1114805, 1114816, 1227530, 1227541, 1286052, 1286063, 1286074, 1286085, 1367513, 1367524, 1367535, 1367546, 1367568, 1367579
ES	Centro de información online de medicamentos de la AEMPS	02213002, 02213007, 02213007IP2, 02213007IP3, 02213007IP4, 02213007IP5, 02213018, 02213018IP1, 02213018IP2, 02213018IP3
FI	Lääkealan turvallisuus- ja kehittämiskeskus	005872, 005894, 010361, 125464, 125475
FR	Base de données publique des médicaments	60570229, 68499809, 69733859
GB	Medicines & Healthcare Products Regulatory Agency	137257, 139322, 147102, 38064, 38071
HK	Department of Health Drug Office	50687, 50688
IE	Health Products Regulatory Authority	34554, 34611, 34629, 34700, 34742, 34811, 39320, 64406, 64444, 64450, 64493, 64494
IT	Agenzia del Farmaco	035608025, 035608076, 035608126
LT	Valstybinė vaistų kontrolės tarnyba	1005142, 1005143, 1011490, 1011491, 1011492, 1011493, 1011494, 1011495, 1011496, 1029736, 1029737, 1029738, 1029739, 1029740, 1029741, 1029742, 1029743, 1031867, 1031868, 1031869, 1031870, 1031871, 1031872
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	559M2001
NL	Z-Index G-Standaard, PRK	67261, 67954, 87386
PL	Rejestru Produktów Leczniczych	100119608, 100119637, 100194863
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W12032001, W12032002, W12032003, W12032004, W12032005, W12032006, W12032007, W12032008, W12033001, W12033002, W12033003, W12033004, W12033005, W12033006, W12033007, W12033008, W53178001, W53178002, W53178003, W53178004, W53178005, W53178006, W53178007
SG	Health Sciences Authority	12394P, 12395P
TN	Direction de la Pharmacie et du Médicament	11533033, 11533034
TR	İlaç ve Tıbbi Cihaz Kurumu	8699693010155